1. Home
  2. GKOS vs REZI Comparison

GKOS vs REZI Comparison

Compare GKOS & REZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$141.22

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo Resideo Technologies Inc.

REZI

Resideo Technologies Inc.

HOLD

Current Price

$40.15

Market Cap

5.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
REZI
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Wholesale Distributors
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.3B
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
GKOS
REZI
Price
$141.22
$40.15
Analyst Decision
Strong Buy
Buy
Analyst Count
12
3
Target Price
$126.92
$39.67
AVG Volume (30 Days)
642.1K
1.1M
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$507,442,000.00
$7,472,000,000.00
Revenue This Year
$23.32
$6.81
Revenue Next Year
$27.43
$3.62
P/E Ratio
N/A
N/A
Revenue Growth
32.33
10.52
52 Week Low
$73.16
$17.22
52 Week High
$145.50
$45.29

Technical Indicators

Market Signals
Indicator
GKOS
REZI
Relative Strength Index (RSI) 73.45 59.99
Support Level $80.14 $39.36
Resistance Level N/A $43.30
Average True Range (ATR) 4.95 1.17
MACD 1.69 0.01
Stochastic Oscillator 86.28 63.54

Price Performance

Historical Comparison
GKOS
REZI

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

Share on Social Networks: